February 22, 2021

Employee Benefit Research Institute: Location, Location, Location: Cost Differences in Health Care Services by Site of Treatment — A Closer Look at Lab, Imaging, and Specialty Medications

It is estimated that 20–30 percent of overall health care spending may be wasteful. The Feb. 18 edition of EBRI’s Issue Brief focuses on waste related to pricing failures when it comes to lab; imaging; and special medications for conditions such as multiple sclerosis, rheumatoid arthritis, and other inflammatory disorders. Takeaways:  In the aggregate, employers […]

April 29, 2020

Community Oncology Alliance Practice Impact Report, April 2020

The 2020 Community Oncology Practice Impact Report documents that 1,748 community oncology clinics and/or practices have closed, been acquired by hospitals, merged, or reported financial struggles since 2008. Data also shows 20.8% increase in practices merging with, or being acquired by, another community oncology practice and/or acquired by a corporate entity since 2018. Read the […]

January 21, 2020

Employee Benefit Research Institute: Cost Differences for Oncology Medicines Based on Site of Treatment

Previous research demonstrates that payments from third-party payers for infused oncology medicines are higher when care is provided in hospital outpatient departments (HOPDs) compared with physician offices (POs). Some have speculated this is due to differences in patient characteristics and treatment regimens between the two sites of care. This study employed a novel analytical approach […]

October 14, 2019

JAMA Network: Trends in Medicare Payment Rates for Noninvasive Cardiac Tests and Association With Testing Location

In settings in which reimbursement depends on test location, higher hospital-based vs practice-based payments were associated with greater proportions of outpatient noninvasive cardiac tests performed in hospital-based locations. A recent study found that site-neutral payments may offer an incentive for testing to be performed in the more efficient location. Read the Study: Trends in Medicare […]

November 1, 2018

Journal of Oncology Practice: Cost Differences Associated With Oncology Care Delivered in a Community Setting Versus a Hospital Setting: A Matched-Claims Analysis of Patients With Breast, Colorectal, and Lung Cancers

Access to high-quality cancer care remains a challenge for many patients. One such barrier is the increasing cost of treatment. With recent shifts in cancer care delivery from community-based to hospital-based clinics, we examined whether this shift could result in increased costs for patients with three common tumor types. Read the full document: Cost Differences […]

April 25, 2018

JAMA Oncology: Chemotherapy Spending Significantly Lower in Physician Offices

A research letter published in JAMA Oncology examined trends in use of and spending for infused chemotherapy in the hospital outpatient department (HOPD) setting compared to the physician office setting from 2004 to 2014 among commercial insured patients. The study found the following: The rate of commercially insured patients receiving chemotherapy in HOPDs increased from […]